Diagnosis

How Is Giant Cell Arteritis Diagnosed? Tests, Criteria & Process

Giant Cell Arteritis diagnosis relies on Full blood count (FBC), Comprehensive metabolic panel (electrolytes, creatinine, LFTs), Urinalysis. Learn the full diagnostic pathway, clinical criteria, differential workup, and what to expect at your evaluation.

Updated March 27, 2026

Clinical Answer

Giant Cell Arteritis is diagnosed using Full blood count (FBC), Comprehensive metabolic panel (electrolytes, creatinine, LFTs), Urinalysis and targeted clinical evaluation. Giant cell arteritis is a vasculitis of large arteries primarily affecting those over 50, causing headache, temporal artery tenderness, jaw claudication, and risk of sudden visual loss. Urgent corticosteroid treatment prevents blindness.

Clinical Context

The diagnostic process for Giant Cell Arteritis begins with Thorough history and physical examination followed by basic blood and urine tests; targeted specialist investigation as needed. Key investigations include Full blood count (FBC), Comprehensive metabolic panel (electrolytes, creatinine, LFTs), Urinalysis, Chest X-ray. The gold standard is: Directed investigation based on clinical history and physical examination findings. Clinical guidelines from NICE / BMJ Best Practice / WHO define the diagnostic criteria and recommended investigation pathway.

How Doctors Confirm the Diagnosis in Practice

Updated March 27, 2026

How Is Giant Cell Arteritis Diagnosed? Tests, Criteria & Process usually becomes clinically useful only when the symptom pattern is read in context rather than as a single isolated phrase. On real pages, people search this question when they are trying to separate benign explanations from higher-risk causes such as Giant Cell Arteritis. The symptom becomes more meaningful when it appears together with associated symptoms, because that combination changes which diagnoses move higher on the differential and which ones can be deprioritised. That is why this page now reinforces the diagnostic path with direct links to the strongest canonical symptom and condition hubs, so Google and users can see a clearer entity relationship instead of another standalone FAQ fragment.

Clinical Pathway

Giant Cell Arteritis — Full Condition GuideCondition HubGiant Cell Arteritis — Differential DiagnosisDifferentialGiant Cell Arteritis — Treatment PathwaysTreatmentGiant Cell Arteritis — Prognosis & OutlookPrognosis

Frequently Asked Questions

How Is Giant Cell Arteritis Diagnosed? Tests, Criteria & Process+

Giant Cell Arteritis is diagnosed using Full blood count (FBC), Comprehensive metabolic panel (electrolytes, creatinine, LFTs), Urinalysis and targeted clinical evaluation. Giant cell arteritis is a vasculitis of large arteries primarily affecting those over 50, causing headache, temporal artery tenderness, jaw claudication, and risk of sudden visual loss. Urgent corticosteroid treatment prevents blindness.

What tests diagnose Giant Cell Arteritis?+

The main tests used to diagnose Giant Cell Arteritis include Full blood count (FBC), Comprehensive metabolic panel (electrolytes, creatinine, LFTs), Urinalysis. Your doctor will select investigations based on your symptoms, clinical findings, and risk factors.

How long does it take to diagnose Giant Cell Arteritis?+

The time to diagnosis varies. Some cases are identified within hours using clinical presentation and blood tests; others require weeks, repeated investigations, or specialist referral.

Can Giant Cell Arteritis be missed on initial testing?+

Yes — Giant Cell Arteritis can be missed if initial tests are negative or if the presentation is atypical. If clinical suspicion remains high, repeat testing or specialist referral is appropriate.

Check Your Symptoms with AI

Our AI Symptom Checker analyzes your symptoms and suggests possible conditions based on clinical guidelines.

Start Free Analysis →
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions. Reviewed by the vHospital Medical Review Board.